Evidence map›Paper›PMID 36680077›Full record

ArticleViruses2022

Geographic and Temporal Variability of Hepatitis E Virus Circulation in the Russian Federation.

Mikhail I Mikhailov, Anastasia A Karlsen, Ilya A Potemkin, Olga V Isaeva, Vera S Kichatova, Elena Yu Malinnikova, Fedor A Asadi Mobarkhan, Eugeniy V Mullin, Maria A Lopatukhina, Victor A Manuylov and 11 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 2 countries.

Mikhail I MikhailovLaboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.
Anastasia A KarlsenLaboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.
Ilya A PotemkinLaboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.ORCID 0000-0001-7559-4219
Olga V IsaevaLaboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.
Vera S KichatovaLaboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.ORCID 0000-0002-7838-6965
Elena Yu MalinnikovaLaboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.
Fedor A Asadi MobarkhanLaboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.
Eugeniy V MullinLaboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.
Maria A LopatukhinaLaboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.
Victor A ManuylovGamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.ORCID 0000-0002-2296-6151
Elena P MazuninaGamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.
Evgeniia N BykoniaGamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.ORCID 0000-0002-2269-1469
Denis A KleymenovGamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.
Liubov I PopovaGamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.
Vladimir A GushchinGamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.ORCID 0000-0002-9397-3762
Artem P TkachukGamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.
Andrey D PolyakovSkolkovo Territorial Department of Rospotrebnadzor in Moscow, 143026 Moscow, Russia.
Ahmed Mohammed EladlyScientific and Educational Resource Center for High-Performance Methods of Genomic Analysis, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia.
Sergey A SoloninN.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health Department, 129090 Moscow, Russia.ORCID 0000-0002-4379-6243
Ilya V GordeychukChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.ORCID 0000-0002-4551-7535
Karen K KyuregyanLaboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.ORCID 0000-0002-3599-117X
Gamalei Institute of Epidemiology and Microbiology · RURussian Medical Academy of Continuous Professional Education · RUPeoples' Friendship University of Russia · RUResearch Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences · RUBelgorod National Research University · RUFederal Service for Surveillance on Consumer Rights Protection and Human Wellbeing · RUResearch Institute of Emergency Care · RURussian Academy of Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The factors influencing hepatitis E virus (HEV) circulation remain largely unexplored. We investigated HEV seroprevalence in humans and the prevalence of infection in farm pigs and rabbits in different regions of the Russian Federation, as well as the genetic diversity and population dynamics of the HEV. The anti-HEV IgG antibody detection rates in the general population increase significantly with age, from 1.5% in children and adolescents under 20 years old to 4.8% in adults aged between 20 and 59 years old to 16.7% in people aged 60 years and older. HEV seroprevalence varies between regions, with the highest rate observed in Belgorod Region (16.4% compared with the national average of 4.6%), which also has the country's highest pig population. When compared with the archival data, both increases and declines in HEV seroprevalence have been observed within the last 10 years, depending on the study region. Virus shedding has been detected in 19 out of the 21 pig farms surveyed. On one farm, the circulation of the same viral strain for five years was documented. All the human and animal strains belonged to the HEV-3 genotype, with its clade 2 sequences being predominant in pigs. The sequences are from patients, pigs, and sewage from pig farms clustered together, suggesting a zoonotic infection in humans and possible environmental contamination. The HEV-3 population size that was predicted using SkyGrid reconstruction demonstrated exponential growth in the 1970s-1990s, with a subsequent decline followed by a short rise around the year 2010, the pattern being similar to the dynamics of the pig population in the country. The HEV-3 reproduction number (Re) that was predicted using birth-death skyline analysis has fluctuated around 1 over the past 20 years in Russia but is 10 times higher in Belgorod Region. In conclusion, the HEV-3 circulation varies both geographically and temporally, even within a single country. The possible factors contributing to this variability are largely related to the circulation of the virus among farm pigs.

Indexed as

Hepatitis EHepatitis E virusSwine DiseasesAdolescentAdultAgedAnimalsChildHumansMiddle AgedPhylogenyRabbitsRNA, ViralRussiaSeroepidemiologic StudiesSwineRNA, Viraldisease outbreakshepatitis E virusmolecular epidemiologyPaslahepevirus balayaniseroprevalencezoonosis

Identifiers

PMID36680077
PMCPMC9865877
OpenAlexW4312117226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.